Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FQ2GA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,529
Award facts
- Contract value 100% obligated
- $24,529.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,529.49 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg in a 2-pen/mL dose formulation on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
Cosentyx is a biologic immunosuppressant medication used to treat autoimmune conditions including psoriasis, psoriatic arthritis, ankylosing spondylitis, and other inflammatory diseases. As a major pharmaceutical distributor serving federal medical procurement, AmerisourceBergen supplies critical medications and medical commodities to support military healthcare systems and the Defense Health Agency. The SPE2DX contract represents a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to military and veteran healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB25FQ2GA?
SPE2DB25FQ2GA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FQ2GA worth?
The government has obligated $24,529 on SPE2DB25FQ2GA.
Is contract SPE2DB25FQ2GA an order under another contract?
Yes. SPE2DB25FQ2GA is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ2GA competed?
The extent of competition for SPE2DB25FQ2GA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award